Consensus of experts from the French Society of Geriatrics and Gerontology on the management of heart failure in very old subjects.

[1]  S. Audia,et al.  [Transthyretin cardiac amyloidosis]. , 2020, La Revue de medecine interne.

[2]  D. Lichtenstein.  Lung ultrasound for the cardiologist-a basic application: The B-profile of the Bedside Lung Ultrasound in Emergencies protocol for diagnosing haemodynamic pulmonary oedema. , 2020, Archives of cardiovascular diseases.

[3]  P. Tuppin,et al.  Outpatient healthcare utilization 30 days before and after hospitalization for heart failure in France: Contribution of the national healthcare database (Systèmenationaldesdonnéesdesanté). , 2020, Archives of cardiovascular diseases.

[4]  D. DeMets,et al.  Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age , 2019, Circulation.

[5]  C. Annweiler,et al.  National survey on the management of heart failure in individuals over 80 years of age in French geriatric care units , 2019, BMC Geriatrics.

[6]  D. M. Tanaka,et al.  A normal sodium diet preserves serum sodium levels during treatment of acute decompensated heart failure: A prospective, blind and randomized trial. , 2019, Clinical nutrition ESPEN.

[7]  P. García-Pavía,et al.  Prevalence of wild type ATTR assessed as myocardial uptake in bone scan in the elderly population. , 2018, International journal of cardiology.

[8]  Huimin Li,et al.  Prognostic Value of Frailty for Older Patients with Heart Failure: A Systematic Review and Meta-Analysis of Prospective Studies , 2018, BioMed research international.

[9]  Sanjiv J. Shah,et al.  Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy , 2018, The New England journal of medicine.

[10]  P. Ponikowski,et al.  Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron‐deficient heart failure patients: an individual patient data meta‐analysis , 2018, European journal of heart failure.

[11]  C. Leclercq,et al.  Effectiveness of a patient education programme in heart failure with preserved ejection fraction: Results from the ODIN cohort study using propensity score matching. , 2018, Archives of cardiovascular diseases.

[12]  Ò. Miró,et al.  Impact of Frailty and Disability on 30-Day Mortality in Older Patients With Acute Heart Failure. , 2017, The American journal of cardiology.

[13]  K. Shah,et al.  Transthyretin Cardiac Amyloidosis , 2017, Current Cardiology Reports.

[14]  M. Komajda,et al.  Brain natriuretic peptide usefulness in very elderly dyspnoeic patients: the BED study , 2017, European journal of heart failure.

[15]  Sanjiv J. Shah,et al.  Mode of Death in Heart Failure With Preserved Ejection Fraction. , 2017, Journal of the American College of Cardiology.

[16]  D. Meyers,et al.  End-of-Life Decisions and Palliative Care in Advanced Heart Failure. , 2016, The Canadian journal of cardiology.

[17]  K. Rockwood.  Conceptual Models of Frailty: Accumulation of Deficits. , 2016, The Canadian journal of cardiology.

[18]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[19]  John G F Cleland,et al.  Structured telephone support or non-invasive telemonitoring for patients with heart failure. , 2015, The Cochrane database of systematic reviews.

[20]  J. Afilalo,et al.  Prognostic and Therapeutic Implications of Frailty in Older Adults with Heart Failure , 2015, Current Cardiology Reports.

[21]  Y. Juillière,et al.  National trends in rate of patients hospitalized for heart failure and heart failure mortality in France, 2000–2012 , 2015, European journal of heart failure.

[22]  D. Mottier,et al.  Functional status and co-morbidities are associated with in-hospital mortality among older patients with acute decompensated heart failure: a multicentre prospective cohort study. , 2015, Age and ageing.

[23]  D. Guthrie,et al.  A Comparison Between End-of-Life Home Care Clients With Cancer and Heart Failure in Ontario , 2015, Home health care services quarterly.

[24]  R. Gary,et al.  Coexisting Frailty, Cognitive Impairment, and Heart Failure: Implications for Clinical Care. , 2015, Journal of clinical outcomes management : JCOM.

[25]  D. Moser,et al.  Dietary sodium restriction below 2 g per day predicted shorter event-free survival in patients with mild heart failure , 2014, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[26]  F. Paccaud,et al.  Two-year outcome of patients after a first hospitalization for heart failure: A national observational study. , 2014, Archives of cardiovascular diseases.

[27]  A. Abernethy,et al.  “Not the ‘Grim Reaper Service’”: An Assessment of Provider Knowledge, Attitudes, and Perceptions Regarding Palliative Care Referral Barriers in Heart Failure , 2014, Journal of the American Heart Association.

[28]  N. Danchin,et al.  Prescription of cardiovascular drugs in the French ODIN cohort of heart failure patients according to age and type of chronic heart failure. , 2014, Archives of cardiovascular diseases.

[29]  F. Paccaud,et al.  First hospitalization for heart failure in France in 2009: patient characteristics and 30-day follow-up. , 2013, Archives of cardiovascular diseases.

[30]  L. Klein,et al.  Prognostic Factors in Patients Hospitalized for Heart Failure , 2013, Current Heart Failure Reports.

[31]  L. Rohde,et al.  IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia. , 2013, International journal of cardiology.

[32]  O. Hanon.  Particularités de l’insuffisance cardiaque du sujet âgé , 2013 .

[33]  I. Piña,et al.  Forecasting the Impact of Heart Failure in the United States: A Policy Statement From the American Heart Association , 2013, Circulation. Heart failure.

[34]  P. Ponikowski,et al.  Iron deficiency in chronic heart failure: an international pooled analysis. , 2013, American heart journal.

[35]  Jeremiah R. Brown,et al.  Palliative care consultations for heart failure patients: how many, when, and why? , 2013, Journal of cardiac failure.

[36]  P. Abete,et al.  Treatment for chronic heart failure in the elderly: current practice and problems , 2013, Heart Failure Reviews.

[37]  J. Cleland,et al.  Diagnosis of elderly patients with heart failure , 2012, European journal of heart failure.

[38]  N. Cook,et al.  Decision Making in Advanced Heart Failure A Scientific Statement From the American Heart Association Endorsed by Heart Failure Society of America, American Association of Heart Failure Nurses, and Society for Medical Decision Making , 2022 .

[39]  Couvreux,et al.  Caractéristiques et trajet de soins des insuffisants cardiaques du régime général. , 2012 .

[40]  L. Køber,et al.  Clinical characteristics and major comorbidities in heart failure patients more than 85 years of age compared with younger age groups , 2011, European journal of heart failure.

[41]  R. McKelvie,et al.  The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care. , 2011, The Canadian journal of cardiology.

[42]  B. Candy,et al.  Palliative care in advanced heart failure: an international review of the perspectives of recipients and health professionals on care provision. , 2011, Journal of cardiac failure.

[43]  B. Billah,et al.  B-type natriuretic peptide-guided heart failure therapy: A meta-analysis. , 2010, Archives of internal medicine.

[44]  H. Krumholz,et al.  Geriatric conditions and subsequent mortality in older patients with heart failure. , 2010, Journal of the American College of Cardiology.

[45]  P. Ponikowski,et al.  Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology , 2009, European journal of heart failure.

[46]  P. Ponikowski,et al.  Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II. , 2008, European heart journal.

[47]  F. Sarullo,et al.  Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure. , 2009, The American journal of cardiology.

[48]  C. Yancy,et al.  The heart failure and sodium restriction controversy: challenging conventional practice. , 2008, Nutrition in clinical practice.

[49]  W Frank Peacock,et al.  State of the art: Using natriuretic peptide levels in clinical practice , 2008, European journal of heart failure.

[50]  J. E. Morley,et al.  The I.A.N.A. task force on frailty assessment of older people in clinical practice , 2008, The journal of nutrition, health & aging.

[51]  P. Abete,et al.  Frailty predicts long‐term mortality in elderly subjects with chronic heart failure , 2005, European journal of clinical investigation.

[52]  Peter C Austin,et al.  Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. , 2003, JAMA.

[53]  Albert W Wu,et al.  Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. , 2003, Journal of the American College of Cardiology.

[54]  F. McAlister,et al.  The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure. , 2002, The American journal of medicine.

[55]  C. Fonseca,et al.  Prevalence of chronic heart failure in Southwestern Europe: the EPICA study , 2002, European journal of heart failure.

[56]  M. Aumont,et al.  Insuffisance cardiaque du sujet âgé , 2001 .

[57]  L. Fried,et al.  Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[58]  L. Lipsitz,et al.  Management of heart failure among very old persons living in long-term care: Has the voice of trials spread? , 2000 .